Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1797)
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
25,000
Price
$25.10
Total Value
$627.50K
Shares Held After
189,669
% of Holdings
11.6%
BIO-TECHNE Corp (TECH)
Herr Amy E. — Director
Shares
6,636
Price
$48.28
Total Value
$320.39K
Shares Held After
200
% of Holdings
97.1%
Axogen, Inc. (AXGN)
Wendell Amy McBride — Director
Shares
1,647
Price
$42.60
Total Value
$70.16K
Shares Held After
93,826
% of Holdings
1.7%
Twist Bioscience Corp (TWST)
WERNER ROBERT F. — Chief Accounting Officer
Shares
4,961
Price
$56.88
Total Value
$282.19K
Shares Held After
49,674
% of Holdings
9.1%
InfuSystem Holdings, Inc (INFU)
GENDRON PAUL ANDREW — Director
Shares
5,000
Price
$8.88
Total Value
$44.40K
Shares Held After
70,000
% of Holdings
7.1%
InfuSystem Holdings, Inc (INFU)
Lachance Carrie — Director
Shares
2,000
Price
$8.83
Total Value
$17.66K
Shares Held After
237,123
% of Holdings
0.8%
InfuSystem Holdings, Inc (INFU)
Steele Barry G — Executive VP and CFO
Shares
7,000
Price
$8.71
Total Value
$60.95K
Shares Held After
96,590
% of Holdings
7.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
3,205
Price
$29.20
Total Value
$93.59K
Shares Held After
1,526,309
% of Holdings
0.2%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
1,582
Price
$28.56
Total Value
$45.18K
Shares Held After
1,529,514
% of Holdings
0.1%
MapLight Therapeutics, Inc. (MPLT)
Kroeger Christopher A. — Director
Shares
29,624
Price
$27.48
Total Value
$814.07K
Shares Held After
1,531,096
% of Holdings
1.9%
Protagonist Therapeutics, Inc (PTGX)
Giraudo Bryan — Director
Shares
5,130
Price
$100.00
Total Value
$513.00K
Shares Held After
12,695
% of Holdings
28.8%
Protagonist Therapeutics, Inc (PTGX)
Giraudo Bryan — Director
Shares
6,000
Price
$100.00
Total Value
$600.00K
Shares Held After
0
% of Holdings
100.0%
GE HealthCare Technologies Inc. (GEHC)
Yang Watkin Phoebe L. — Director
Shares
1,000
Price
$63.01
Total Value
$63.01K
Shares Held After
13,702
% of Holdings
7.3%
LEMAITRE VASCULAR INC (LMAT)
LeMaitre George W — Director
Shares
27,881
Price
$108.69
Total Value
$3.03M
Shares Held After
1,430,019
% of Holdings
1.9%
Sionna Therapeutics, Inc. (SION)
ORBIMED ADVISORS LLC — Director
Shares
59,767
Price
$44.58
Total Value
$2.66M
Shares Held After
2,856,461
% of Holdings
2.0%
Alphatec Holdings, Inc. (ATEC)
Valentine Keith — Director
Shares
43,847
Price
$7.54
Total Value
$330.61K
Shares Held After
197,271
% of Holdings
22.2%
Sionna Therapeutics, Inc. (SION)
Thompson Peter A. — Director
Shares
59,767
Price
$44.58
Total Value
$2.66M
Shares Held After
2,856,461
% of Holdings
2.0%
Inspire Medical Systems, Inc. (INSP)
mcCormick Shawn — Director
Shares
696
Price
$45.31
Total Value
$31.54K
Shares Held After
27,712
% of Holdings
2.5%
908 Devices Inc. (MASS)
Kenneweg John — SVP, Sales & Product Marketing
Shares
18,255
Price
$8.11
Total Value
$148.05K
Shares Held After
57,784
% of Holdings
24.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
950
Price
$68.35
Total Value
$64.93K
Shares Held After
4,358,447
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,076
Price
$67.35
Total Value
$341.85K
Shares Held After
4,359,397
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
13,974
Price
$66.65
Total Value
$931.37K
Shares Held After
4,364,473
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
950
Price
$68.35
Total Value
$64.93K
Shares Held After
555,686
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,077
Price
$67.35
Total Value
$341.91K
Shares Held After
556,636
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
13,973
Price
$66.65
Total Value
$931.31K
Shares Held After
561,713
% of Holdings
2.4%
CVS HEALTH Corp (CVS)
Mandadi Tilak — EVP, Chief Exp & Tech Officer
Shares
69,551
Price
$89.58
Total Value
$6.23M
Shares Held After
10,133
% of Holdings
87.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Soteropoulos Paula — Director
Shares
599
Price
$85.47
Total Value
$51.20K
Shares Held After
0
% of Holdings
100.0%
Rapport Therapeutics, Inc. (RAPP)
Third Rock Ventures V, L.P. — 10% Owner
Shares
5,018
Price
$40.31
Total Value
$202.26K
Shares Held After
6,432,715
% of Holdings
0.1%
Concentra Group Holdings Parent, Inc. (CON)
ORTENZIO ROBERT A — Director
Shares
130,000
Price
$25.00
Total Value
$3.25M
Shares Held After
893,455
% of Holdings
12.7%
LEMAITRE VASCULAR INC (LMAT)
Kamke Trent G — Senior V. P., Operations
Shares
2,928
Price
$107.00
Total Value
$313.29K
Shares Held After
3,749
% of Holdings
43.9%
Avantor, Inc. (AVTR)
LUCIER GREGORY T — Director
Shares
10,000
Price
$8.32
Total Value
$83.20K
Shares Held After
60,000
% of Holdings
16.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$571.66
Total Value
$297.27K
Shares Held After
40,513
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
495
Price
$570.22
Total Value
$282.26K
Shares Held After
41,033
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
106
Price
$569.61
Total Value
$60.38K
Shares Held After
41,528
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$568.16
Total Value
$204.54K
Shares Held After
41,634
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
319
Price
$567.21
Total Value
$180.94K
Shares Held After
41,994
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
705
Price
$565.99
Total Value
$399.02K
Shares Held After
42,313
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,983
Price
$564.77
Total Value
$1.12M
Shares Held After
43,018
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,864
Price
$564.00
Total Value
$1.05M
Shares Held After
45,001
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,022
Price
$563.06
Total Value
$1.14M
Shares Held After
46,865
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,126
Price
$562.08
Total Value
$632.91K
Shares Held After
48,887
% of Holdings
2.3%
MBX Biosciences, Inc. (MBX)
Azoulay Salomon — Chief Medical Officer
Shares
15,003
Price
$38.30
Total Value
$574.61K
Shares Held After
14,769
% of Holdings
50.4%
MBX Biosciences, Inc. (MBX)
Azoulay Salomon — Chief Medical Officer
Shares
55,000
Price
$38.38
Total Value
$2.11M
Shares Held After
14,769
% of Holdings
78.8%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
10,000
Price
$30.00
Total Value
$300.00K
Shares Held After
134,985
% of Holdings
6.9%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
19,269
Price
$75.35
Total Value
$1.45M
Shares Held After
88,606
% of Holdings
17.9%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
24,814
Price
$74.76
Total Value
$1.86M
Shares Held After
107,875
% of Holdings
18.7%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
33,513
Price
$73.72
Total Value
$2.47M
Shares Held After
132,689
% of Holdings
20.2%
Spyre Therapeutics, Inc. (SYRE)
HENDERSON MICHAEL THOMAS — Director
Shares
2,404
Price
$72.57
Total Value
$174.46K
Shares Held After
166,202
% of Holdings
1.4%
908 Devices Inc. (MASS)
AWM Investment Company, Inc. — 10% Owner
Shares
3,025
Price
$8.20
Total Value
$24.80K
Shares Held After
5,121,715
% of Holdings
0.1%
CHEMED CORP (CHE)
GRACE PATRICK P — Director
Shares
60
Price
$425.78
Total Value
$25.55K
Shares Held After
3,337
% of Holdings
1.8%
Showing 1201–1250 of 1797 transactions (page 25 of 36)